{"log_id": 8266736142814293172, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 1.1e-05, "average": 0.997713, "min": 0.990538}, "location": {"width": 133, "top": 203, "height": 29, "left": 212}, "words": "【药理毒理】"}, {"probability": {"variance": 2e-06, "average": 0.997551, "min": 0.995946}, "location": {"width": 101, "top": 253, "height": 28, "left": 206}, "words": "作用机理"}, {"probability": {"variance": 0.000634, "average": 0.973001, "min": 0.947827}, "location": {"width": 51, "top": 302, "height": 27, "left": 212}, "words": "本品"}, {"probability": {"variance": 8e-06, "average": 0.998371, "min": 0.984391}, "location": {"width": 829, "top": 330, "height": 50, "left": 209}, "words": "本品是将两种作用机制互补的降血糖药物联合起来,用于改善2型糖尿病患者的"}, {"probability": {"variance": 1.6e-05, "average": 0.997228, "min": 0.987139}, "location": {"width": 808, "top": 379, "height": 47, "left": 211}, "words": "血糖控制:药物成分中的磷酸西格列汀是一种二肽基肽酶4(DPP-4)抑制剂"}, {"probability": {"variance": 0.000248, "average": 0.991167, "min": 0.936412}, "location": {"width": 435, "top": 433, "height": 40, "left": 212}, "words": "而盐酸二甲双胍一种是双胍类降血糖药物"}, {"probability": {"variance": 0, "average": 0.999135, "min": 0.998517}, "location": {"width": 149, "top": 532, "height": 29, "left": 217}, "words": "磷酸西格列汀"}, {"probability": {"variance": 0.00118, "average": 0.987822, "min": 0.806338}, "location": {"width": 819, "top": 561, "height": 49, "left": 216}, "words": "磷酸西格列汀是一类所谓二肽基肽酶4(DPP4)抑制剂的口服降血糖药中的一种"}, {"probability": {"variance": 1.5e-05, "average": 0.998378, "min": 0.980246}, "location": {"width": 830, "top": 609, "height": 48, "left": 218}, "words": "它可以通过提高活性肠促胰素的水平,来改善2型糖尿病患者血糖的控制。肠促"}, {"probability": {"variance": 0.000103, "average": 0.995964, "min": 0.950296}, "location": {"width": 828, "top": 656, "height": 48, "left": 219}, "words": "胰岛激素含有胰高血糖素样多肽-1(GLP-1)和葡萄糖依赖性促胰岛素分泌多肽"}, {"probability": {"variance": 5.4e-05, "average": 0.995902, "min": 0.967647}, "location": {"width": 819, "top": 704, "height": 47, "left": 231}, "words": "(GIP),它主要是在白天由肠道分泌产生,且餐后水平会升高。肠促胰岛激素"}, {"probability": {"variance": 0.000314, "average": 0.995427, "min": 0.897576}, "location": {"width": 815, "top": 752, "height": 46, "left": 220}, "words": "作为内源性系统的一部分,参与全身血糖稳态的调节。当血糖浓度正常或升高时"}, {"probability": {"variance": 0.005153, "average": 0.971617, "min": 0.664412}, "location": {"width": 817, "top": 798, "height": 49, "left": 221}, "words": "GLP-1和GIP通过环AMP相关的细胞内信号途径刺激胰β细胞合成和释放胰岛素"}, {"probability": {"variance": 0.000559, "average": 0.990447, "min": 0.869499}, "location": {"width": 829, "top": 846, "height": 47, "left": 224}, "words": "在治疗2型糖尿病的动物模型中发现,GLP-1或DPP4抑制剂可以改善β细胞对血糖"}, {"probability": {"variance": 0.000109, "average": 0.995463, "min": 0.949954}, "location": {"width": 826, "top": 893, "height": 47, "left": 225}, "words": "变化的反应,并促进胰岛素的生物合成和释放。随着胰岛素水平的升高,组织对"}, {"probability": {"variance": 0.005896, "average": 0.971327, "min": 0.571248}, "location": {"width": 830, "top": 940, "height": 48, "left": 226}, "words": "葡萄糖的摄取也增加。另外,GLP-1还可以降低胰腺a细胞分泌的胰高糖素。胰"}, {"probability": {"variance": 0.000284, "average": 0.995094, "min": 0.900992}, "location": {"width": 828, "top": 987, "height": 48, "left": 227}, "words": "高血糖素浓度的降低和胰岛素水平的升高,可以减少肝脏葡萄糖的产生,导致血"}, {"probability": {"variance": 0.000635, "average": 0.991805, "min": 0.863062}, "location": {"width": 802, "top": 1035, "height": 47, "left": 228}, "words": "糖水平的下降。GLP-1和GIP的效果是葡萄糖依赖的,以至于当血糖浓度低时"}, {"probability": {"variance": 0.001239, "average": 0.992441, "min": 0.782744}, "location": {"width": 825, "top": 1081, "height": 47, "left": 233}, "words": "GLP-1的刺激胰岛素分泌和抑制胰高糖素分泌的作用并不明显。当患者的血糖浓"}, {"probability": {"variance": 0.001875, "average": 0.9877, "min": 0.754693}, "location": {"width": 803, "top": 1128, "height": 48, "left": 231}, "words": "度升高超过正常水平时,GLP-1和GIP刺激胰岛素释放的作用都会增强。而且"}, {"probability": {"variance": 0.003396, "average": 0.978863, "min": 0.675938}, "location": {"width": 820, "top": 1176, "height": 47, "left": 239}, "words": "GLP-1不会破坏胰高血糖素对低血糖的正常反应。GLP-1和GIP的作用受到DPP-4"}, {"probability": {"variance": 8.3e-05, "average": 0.995744, "min": 0.947585}, "location": {"width": 827, "top": 1224, "height": 46, "left": 233}, "words": "酶的限制。这种酶可以迅速水解肠促胰岛激素生成非活性物质。西格列汀可以防"}, {"probability": {"variance": 0.007161, "average": 0.976139, "min": 0.468026}, "location": {"width": 829, "top": 1272, "height": 45, "left": 235}, "words": "止肠促胰岛激素被DPP-4水解,因此可以升高血浆内活性GLP-1和GIP的浓度。西"}, {"probability": {"variance": 3e-06, "average": 0.998785, "min": 0.994036}, "location": {"width": 827, "top": 1318, "height": 46, "left": 236}, "words": "格列汀是通过提高活性肠促胰岛激素的水平来增加胰岛素的释放并降低胰高糖"}, {"probability": {"variance": 0.003316, "average": 0.988393, "min": 0.653395}, "location": {"width": 827, "top": 1364, "height": 46, "left": 237}, "words": "素水平,且这种作用呈葡萄糖依赖性。对于血糖高的2型糖尿病患者而言,胰岛"}, {"probability": {"variance": 0.003227, "average": 0.982021, "min": 0.670479}, "location": {"width": 825, "top": 1412, "height": 46, "left": 238}, "words": "素和胰高糖素水平的上述变化会使血红蛋白A1c(HbA1c)水平和空腹、餐后的血"}, {"probability": {"variance": 6e-06, "average": 0.998388, "min": 0.987941}, "location": {"width": 827, "top": 1459, "height": 46, "left": 238}, "words": "糖浓度都降低。即使在体内血糖水平很低的时候,磺酰脲类药物仍然可以促进胰"}, {"probability": {"variance": 2.6e-05, "average": 0.998226, "min": 0.971601}, "location": {"width": 826, "top": 1505, "height": 47, "left": 241}, "words": "岛素的分泌,并且导致2型糖尿病患者和正常人出现低血糖。西格列汀的上述葡"}, {"probability": {"variance": 2.4e-05, "average": 0.997056, "min": 0.975978}, "location": {"width": 825, "top": 1553, "height": 46, "left": 241}, "words": "萄糖依赖的作用机制与磺酰脲类药物是截然不同的。西格列汀是一种强效、高选"}], "language": 3}